General Information of the Compound
Compound ID
CP0500604
Compound Name
2-(3-(6-chloroimidazo[2,1-b]thiazol-5-ylsulfonyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)ethanamine
    Show/Hide
Structure
Formula
C14H12ClN5O2S2
Molecular Weight
381.87
Canonical SMILES
NCCn1cc(c2ncccc12)S(=O)(=O)c1c(Cl)nc2sccn12
    Show/Hide
InChI
InChI=1S/C14H12ClN5O2S2/c15-12-13(20-6-7-23-14(20)18-12)24(21,22)10-8-19(5-3-16)9-2-1-4-17-11(9)10/h1-2,4,6-8H,3,5,16H2
    Show/Hide
InChIKey
KBAUSYLLJIMALV-UHFFFAOYSA-N
Physicochemical Property
logP
2.1904
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
95.28
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45487100
ChEMBL ID
CHEMBL572087
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
Ki = 42 nM
   TI
   LI
   LO
   TS